New patent expiration for Astrazeneca Ab drug SYMLIN

Annual Drug Patent Expirations for SYMLIN Symlin is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are two patents… The post New patent expiration for Astrazeneca Ab drug SYMLIN appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: